A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus

Documenti analoghi

• A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus.
  di: Mackworth-Young, C G, et al.
  Pubblicazione: (1988)
• Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial
  di: Petri, Michelle, et al.
  Pubblicazione: (2011)
• Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial
  di: Thomas Dörner, et al.
  Pubblicazione: (2022-05-01)
• Pathophysiology of cutaneous lupus erythematosus
  di: Achtman, Jordan C, et al.
  Pubblicazione: (2015)
• Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
  di: Tarazi, Meera, et al.
  Pubblicazione: (2018)